-
December 1: The Week in Cancer News
FDA announces investigation into CAR T-cell therapy, and precision therapies are not available for most cancer diagnoses.
by Kevin McLaughlin
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
November 17: The Week in Cancer News
Study finds association between vitamin D levels and risk for peripheral neuropathy, and new report highlights rising lung cancer survival.
by Thomas Celona
-
Progress in Lung Cancer
November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
-
November 10: The Week in Cancer News
Sun exposure is an occupational hazard around the globe, and a dormant virus can cause immunotherapy complications.
by Eric Fitzsimmons
-
Against All Odds
At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren
-
November 3: The Week in Cancer News
Recommendation suggests ongoing lung cancer screening for those with heavy smoking history even after quitting, and children with Down syndrome and leukemia face worse outcomes.
by Marci A. Landsmann
-
Finding the ‘Silent Killer’
Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.
by Eve Spiegel
-
October 27: The Week in Cancer News
Living alone may increase the risk of cancer death, and cervical cancer study results called ‘remarkable.’
by Kevin McLaughlin
Cancer Talk
Cancer Today Editors’ Picks: 2024
Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
De-escalating Treatment for DCISResearch finds certain people with low-risk DCIS may be able to forgo surgery or radiation.
by Thomas Celona
Study Highlights Challenges in Pancreatic Cancer StagingMost pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles